These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 22692213)
1. The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. Zhou L; Barão S; Laga M; Bockstael K; Borgers M; Gijsen H; Annaert W; Moechars D; Mercken M; Gevaert K; De Strooper B J Biol Chem; 2012 Jul; 287(31):25927-40. PubMed ID: 22692213 [TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo. Kim W; Watanabe H; Lomoio S; Tesco G J Biol Chem; 2021; 296():100372. PubMed ID: 33548223 [TBL] [Abstract][Full Text] [Related]
3. β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. Hitt B; Riordan SM; Kukreja L; Eimer WA; Rajapaksha TW; Vassar R J Biol Chem; 2012 Nov; 287(46):38408-25. PubMed ID: 22988240 [TBL] [Abstract][Full Text] [Related]
4. α-secretase ADAM10 physically interacts with β-secretase BACE1 in neurons and regulates CHL1 proteolysis. Wang X; Wang C; Pei G J Mol Cell Biol; 2018 Oct; 10(5):411-422. PubMed ID: 29325091 [TBL] [Abstract][Full Text] [Related]
5. Click Chemistry-mediated Biotinylation Reveals a Function for the Protease BACE1 in Modulating the Neuronal Surface Glycoproteome. Herber J; Njavro J; Feederle R; Schepers U; Müller UC; Bräse S; Müller SA; Lichtenthaler SF Mol Cell Proteomics; 2018 Aug; 17(8):1487-1501. PubMed ID: 29716987 [TBL] [Abstract][Full Text] [Related]
6. New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models. Resende R; Ferreira-Marques M; Moreira P; Coimbra JRM; Baptista SJ; Isidoro C; Salvador JAR; Dinis TCP; Pereira CF; Santos AE J Alzheimers Dis; 2020; 76(4):1317-1337. PubMed ID: 32597812 [TBL] [Abstract][Full Text] [Related]
8. Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells. Kamikubo Y; Takasugi N; Niisato K; Hashimoto Y; Sakurai T J Alzheimers Dis; 2017; 56(2):641-653. PubMed ID: 28035928 [TBL] [Abstract][Full Text] [Related]
9. Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1. Rudan Njavro J; Klotz J; Dislich B; Wanngren J; Shmueli MD; Herber J; Kuhn PH; Kumar R; Koeglsperger T; Conrad M; Wurst W; Feederle R; Vlachos A; Michalakis S; Jedlicka P; Müller SA; Lichtenthaler SF FASEB J; 2020 Feb; 34(2):2465-2482. PubMed ID: 31908000 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1. Zhou L; Chávez-Gutiérrez L; Bockstael K; Sannerud R; Annaert W; May PC; Karran E; De Strooper B J Biol Chem; 2011 Mar; 286(10):8677-8687. PubMed ID: 21209097 [TBL] [Abstract][Full Text] [Related]
11. Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons. Pigoni M; Wanngren J; Kuhn PH; Munro KM; Gunnersen JM; Takeshima H; Feederle R; Voytyuk I; De Strooper B; Levasseur MD; Hrupka BJ; Müller SA; Lichtenthaler SF Mol Neurodegener; 2016 Oct; 11(1):67. PubMed ID: 27716410 [TBL] [Abstract][Full Text] [Related]
12. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Ou-Yang MH; Kurz JE; Nomura T; Popovic J; Rajapaksha TW; Dong H; Contractor A; Chetkovich DM; Tourtellotte WG; Vassar R Sci Transl Med; 2018 Sep; 10(459):. PubMed ID: 30232227 [TBL] [Abstract][Full Text] [Related]
13. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence. Kimura A; Hata S; Suzuki T J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728 [TBL] [Abstract][Full Text] [Related]
14. Editorial: Implications for BACE1 Inhibitor Clinical Trials: Adult Conditional BACE1 Knockout Mice Exhibit Axonal Organization Defects in the Hippocampus. Vassar R J Prev Alzheimers Dis; 2019; 6(2):78-84. PubMed ID: 30756113 [TBL] [Abstract][Full Text] [Related]
15. BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease. Barão S; Moechars D; Lichtenthaler SF; De Strooper B Trends Neurosci; 2016 Mar; 39(3):158-169. PubMed ID: 26833257 [TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice. Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745 [TBL] [Abstract][Full Text] [Related]
20. Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System. Munro KM; Nash A; Pigoni M; Lichtenthaler SF; Gunnersen JM J Mol Neurosci; 2016 Nov; 60(3):305-315. PubMed ID: 27456313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]